As we have seen in the last post, marijuana is legalized in 4 out of the 50 states of the USA. However, medicinal cannabis is legalized in a total of 18 states.
With more and more states legalizing this medicinal cannabis, the medical cannabis industry is getting busy in order to make profit from this promising market. According to See Change Strategy, a research firm specialized in new markets, the medicinal cannabis business market represent 2 billion dollars and it could be 9 billion dollars if other states were willing to legalize marijuana for medical use.
The leading company in this market is GW Pharma. It is a british company that has been founded in 1998. Their product is called Sativex.
Sativex is an oral spray sold mainly in Europe for the moment but it will soon probably extends to the USA. Sativex has strong partners with pharmaceuticals giants Bayer and Novartis. It is a cure against spasms caused by multiple sclerosis and it is free of known psychotic effects of cannabis.
GW Pharma is currently trying to validate step by step clinicalt trials in order to market Sativex for other diseases.